Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 |
Description | CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM). |
Targets&IC50 | CDK9:1.8 nM, CDK2:155 nM |
In vitro | CDK9-IN-9 (example 2) inhibits the proliferation of HeLa, HeLa-MaTu-ADR, DU145, NCI-H460, Caco-2, B16F10, A2780 and MOLM-13 cells (IC50s: 4.4 nM, 5.3 nM, 4.5 nM, 9.2 nM, 8.4 nM, 1.2 nM, 1.2 nM, 2.0 nM). |
Molecular Weight | 459.51 |
Formula | C22H23F2N5O2S |
CAS No. | 2246956-84-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK9-IN-9 2246956-84-1 Cell Cycle/Checkpoint CDK CDK9 IN 9 CDK9IN9 CDK-9-IN-9 inhibitor inhibit